Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma.

Subjects

Subjects :

Humans
Nivolumab adverse effects
Immune Checkpoint Inhibitors
Carcinoma, Renal Cell drug therapy
Melanoma drug therapy
Melanoma pathology
Melanoma secondary
Kidney Neoplasms drug therapy
Kidney Neoplasms pathology
Heart Transplantation adverse effects

Details

Language :

English

ISSN :

1557-3117

Volume :

41

Issue :

12

Database :

MEDLINE

Journal :

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Publication Type :

Report

Accession number :

36220718

Full Text :

https://doi.org/10.1016/j.healun.2022.08.004